NIH-funded research R01 grant

Improving statin prescribing to lower heart disease risk

Official title: EHR Nudges: Optimizing a Clinical Decision Support System for Evidence-Based Statin Medication Prescribing to Reduce the Risk of Cardiovascular Disease

Funded at New York University School of Medicine · NIH-10999412 · Data updated 2026-11-12

This study is looking at how to make it easier for doctors to prescribe statin medications to patients at risk of heart disease by using helpful reminders in their electronic health records, so they can make better decisions without feeling overwhelmed.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startJanuary 1, 2024
Project endDecember 31, 2028
Funding year2025
Award (this year)$684,618
NIH project number5R01HL171292-02
Project IDNIH-10999412 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who meet the clinical guidelines for statin therapy due to their risk of cardiovascular disease.

Less likely to help

Patients who do not meet the criteria for statin therapy or those who are already receiving optimal treatment may not benefit from this research.

What this research studies

This research aims to enhance the use of clinical decision support systems (CDSS) within electronic health records (EHR) to promote the appropriate prescribing of statin medications for patients at risk of cardiovascular disease. By integrating behavioral economics principles, the project seeks to address the barriers that healthcare providers face, such as time constraints and cognitive overload, which often lead to under-prescribing of statins. The study will implement 'nudges'—subtle prompts that encourage better decision-making—within the CDSS to facilitate guideline-concordant prescribing practices. This approach is designed to make it easier for providers to recognize and manage cardiovascular disease risk effectively.

Why it matters

Potential benefit: If successful, this research could significantly increase the number of patients receiving appropriate statin therapy, thereby reducing their risk of cardiovascular events and improving overall heart health.

How similar studies have gone: Previous research has shown that integrating behavioral economics into clinical decision-making can lead to improved health outcomes, suggesting that this approach may be effective.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Richardson, Safiya — New York University School of Medicine
  • Study coordinator: Richardson, Safiya

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.